Citadel Advisors
INMB icon

Citadel Advisors’s INmune Bio INMB Stock Holding History

Citadel Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,511
Closed -$745K – 13744
2025
Q1 		$793K Buy
101,511
+49,314
+94% +$392K ﹤0.01% 7466
2024
Q4 		$244K Buy
52,197
+6,081
+13% +$31.7K ﹤0.01% 10085
2024
Q3 		$249K Buy
46,116
+15,426
+50% +$110K ﹤0.01% 9690
2024
Q2 		$271K Buy
30,690
+30,660
+102,200% +$302K ﹤0.01% 9339
2024
Q1 		$353 Sell
30
-33,821
-100% -$409K ﹤0.01% 14354
2023
Q4 		$381K Buy
33,851
+19,596
+137% +$164K ﹤0.01% 8669
2023
Q3 		$97.5K Sell
14,255
-25,585
-64% -$212K ﹤0.01% 10933
2023
Q2 		$362K Buy
39,840
+1,130
+3% +$9.08K ﹤0.01% 8644
2023
Q1 		$250K Sell
38,710
-3,316
-8% -$26.7K ﹤0.01% 9763
2022
Q4 		$266K Buy
42,026
+15,894
+61% +$113K ﹤0.01% 9569
2022
Q3 		$162K Buy
26,132
+9,469
+57% +$83.1K ﹤0.01% 10626
2022
Q2 		$147K Sell
16,663
-9,803
-37% -$73K ﹤0.01% 11005
2022
Q1 		$223K Sell
26,466
-41,427
-61% -$372K ﹤0.01% 11265
2021
Q4 		$693K Buy
67,893
+15,201
+29% +$225K ﹤0.01% 8868
2021
Q3 		$1.02M Sell
52,692
-3,364
-6% -$65K ﹤0.01% 8096
2021
Q2 		$985K Buy
+56,056
New +$755K ﹤0.01% 8406
2019
Q2 		– Sell
-10,191
Closed -$80K – 9500
2019
Q1 		$80K Buy
+10,191
New +$78.9K ﹤0.01% 8635

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's INMB Position: Q2 2025 in Review

Citadel Advisors sold out of INmune Bio (INMB) in Q2 2025, closing a stake of 101,511 shares — an estimated $745K sold.

Citadel Advisors first reported a position in INMB in Q1 2019 and held it in 17 quarters. The position peaked at $1.02M in Q3 2021. 79 funds tracked by Wall St. Rank hold INMB as of Q2 2025.

  • Citadel Advisors reported no remaining INmune Bio position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 101,511 INmune Bio shares in Q2 2025, an estimated $745K.
  • Citadel Advisors first reported a position in INmune Bio in Q1 2019 and held it in 17 quarters.
  • Citadel Advisors's INmune Bio position peaked at $1.02M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held INmune Bio as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.